1. Home
  2. BBIO vs HIMS Comparison

BBIO vs HIMS Comparison

Compare BBIO & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • HIMS
  • Stock Information
  • Founded
  • BBIO 2015
  • HIMS 2017
  • Country
  • BBIO United States
  • HIMS United States
  • Employees
  • BBIO N/A
  • HIMS N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • HIMS Medical/Nursing Services
  • Sector
  • BBIO Health Care
  • HIMS Health Care
  • Exchange
  • BBIO Nasdaq
  • HIMS Nasdaq
  • Market Cap
  • BBIO 4.7B
  • HIMS 4.1B
  • IPO Year
  • BBIO 2019
  • HIMS N/A
  • Fundamental
  • Price
  • BBIO $26.19
  • HIMS $21.55
  • Analyst Decision
  • BBIO Strong Buy
  • HIMS Buy
  • Analyst Count
  • BBIO 13
  • HIMS 12
  • Target Price
  • BBIO $46.83
  • HIMS $20.50
  • AVG Volume (30 Days)
  • BBIO 1.9M
  • HIMS 12.3M
  • Earning Date
  • BBIO 10-31-2024
  • HIMS 11-04-2024
  • Dividend Yield
  • BBIO N/A
  • HIMS N/A
  • EPS Growth
  • BBIO N/A
  • HIMS N/A
  • EPS
  • BBIO N/A
  • HIMS 0.08
  • Revenue
  • BBIO $219,124,000.00
  • HIMS $1,067,137,000.00
  • Revenue This Year
  • BBIO $4,080.05
  • HIMS $62.61
  • Revenue Next Year
  • BBIO N/A
  • HIMS $35.90
  • P/E Ratio
  • BBIO N/A
  • HIMS $264.09
  • Revenue Growth
  • BBIO 3761.22
  • HIMS 50.15
  • 52 Week Low
  • BBIO $21.62
  • HIMS $5.65
  • 52 Week High
  • BBIO $44.32
  • HIMS $25.74
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 53.03
  • HIMS 64.02
  • Support Level
  • BBIO $25.16
  • HIMS $17.36
  • Resistance Level
  • BBIO $26.78
  • HIMS $23.07
  • Average True Range (ATR)
  • BBIO 1.17
  • HIMS 1.25
  • MACD
  • BBIO 0.19
  • HIMS 0.40
  • Stochastic Oscillator
  • BBIO 85.36
  • HIMS 78.35

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology.

About HIMS Hims & Hers Health Inc.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Share on Social Networks: